BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) Stock Price

BRTXStock

$0.22−86.07%52W

Market Cap$5.67M

P/E—

PEG Ratio—

Div yield—

Beta0.81

BRTX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-32.28%

Price vs S&P 500 (4W)-23.08%

VGM Score32.22

Book Value / Share (Quarterly)$0.12

P/TBV (Annual)1.25x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)44.18%

Cash Flow / Share (Quarterly)$-0.47

Price vs S&P 500 (YTD)-93.81%

Gross Margin (TTM)92.08%

Net Profit Margin (TTM)-3089.55%

EPS (TTM)$-1.09

10-Day Avg Trading Volume0.21M

EPS Excl Extra (TTM)$-1.09

Revenue Growth (5Y)35.07%

EPS (Annual)$-1.58

ROI (Annual)-3992.26%

Gross Margin (Annual)93.37%

Net Profit Margin (5Y Avg)-23470.44%

Cash / Share (Quarterly)$0.14

Revenue Growth QoQ (YoY)-7.32%

ROA (Last FY)-349.10%

Revenue Growth TTM (YoY)-8.47%

EBITD / Share (TTM)$-1.24

ROE (5Y Avg)-904.71%

Operating Margin (TTM)-3975.00%

Cash Flow / Share (Annual)$-1.23

P/B Ratio1.85x

P/B Ratio (Quarterly)2.29x

Net Income / Employee (Annual)$-1,095,500

EV / Revenue (TTM)6.98x

Net Interest Coverage (TTM)-23.34x

ROA (TTM)-193.30%

EPS Incl Extra (Annual)$-1.58

Current Ratio (Annual)0.84x

Quick Ratio (Quarterly)2.23x

3-Month Avg Trading Volume7.29M

52-Week Price Return-86.07%

Revenue / Employee (TTM)$27,500

Tangible BV / Share (Quarterly)$0.10

P/S Ratio (Annual)15.60x

Asset Turnover (Annual)0.09x

52-Week High$1.89

Operating Margin (5Y Avg)-23650.23%

EPS Excl Extra (Annual)$-1.58

CapEx CAGR (5Y)21.56%

26-Week Price Return-21.04%

Quick Ratio (Annual)0.80x

13-Week Price Return10.47%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.35x

Enterprise Value$2.50M

Revenue / Share Growth (5Y)-27.89%

Asset Turnover (TTM)0.06x

Revenue / Employee (Annual)$27,700

Inventory Turnover (Annual)21.00x

Pretax Margin (Annual)-3959.41%

Cash / Share (Annual)$0.33

3-Month Return Std Dev181.13%

Gross Margin (5Y Avg)89.02%

Net Income / Employee (TTM)$-850,500

ROE (Last FY)-3992.26%

Net Interest Coverage (Annual)-107.00x

EPS Basic Excl Extra (Annual)$-1.58

Receivables Turnover (TTM)18.69x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.09

Receivables Turnover (Annual)3.53x

ROI (TTM)-423.84%

P/S Ratio (TTM)15.68x

Pretax Margin (5Y Avg)-23470.44%

Revenue / Share (Annual)$0.04

Tangible BV / Share (Annual)$1.14

Price vs S&P 500 (52W)-104.38%

Year-to-Date Return-81.86%

5-Day Price Return0.09%

EPS Normalized (Annual)$-1.58

ROA (5Y Avg)-162.94%

Net Profit Margin (Annual)-3959.41%

Month-to-Date Return4.15%

Cash Flow / Share (TTM)$-3.99

EBITD / Share (Annual)$-1.72

Operating Margin (Annual)-4350.05%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-904.24%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.09

P/TBV (Quarterly)2.76x

P/B Ratio (Annual)29.23x

Inventory Turnover (TTM)31.00x

Pretax Margin (TTM)-3089.55%

Book Value / Share (Annual)$0.04

Price vs S&P 500 (13W)7.67%

Beta0.81x

Revenue / Share (TTM)$0.02

ROE (TTM)-423.84%

52-Week Low$0.16

vGradeD

gGradeD

mGradeD

vgmGradeD

BRTX Earnings Surprise History

Q2 25-0.30est. -0.41

Q3 25-0.33est. -0.38

Q4 25-0.32est. -0.37

Q1 26-0.12est. -0.30

BRTX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

Industry Peers — Health Services(17)

Symbol	Value Score	Growth Score	Momentum Score	Price
BRTXBioRestorative Therapies, Inc. Common Stock (NV)	D	D	D	$0.22
FMSFresenius Medical Care AG	A	D	D	$23.51
DVADaVita Inc.	B	C	C	$177.80
SHCSotera Health Company Common Stock	D	B	B	$19.51
PGNYProgyny, Inc. Common Stock	C	B	C	$25.82
AGLagilon health, inc.	B	B	B	$96.11
MCTACharming Medical Limited Class A Ordinary Shares	F	F	A	$29.36
VMDViemed Healthcare, Inc. Common Shares	B	C	C	$9.10
PARKPark Dental Partners, Inc. Common Stock	B	C	C	$20.46
CCELCryo-Cell International Inc.	C	D	B	$4.30
MGRXMangoceuticals, Inc. Common Stock	D	F	D	$0.39
NIVFNewGenIvf Group Limited Class A ordinary shares	A	B	F	$0.55
NIVFWNewGenIvf Group Limited Warrants	—	—	D	$0.02
OAKUOak Woods Acquisition Corporation Class A Ordinary Shares	—	F	C	$0.00
OAKUROak Woods Acquisition Corporation Right	—	F	C	$0.00
OAKUUOak Woods Acquisition Corporation Unit	—	F	C	$0.00
OAKUWOak Woods Acquisition Corporation Warrant	—	—	F	$0.00
QIPTQuipt Home Medical Corp. Ordinary Shares	B	B	B	$0.00

About BioRestorative Therapies, Inc. Common Stock (NV)

BioRestorative Therapies is a biotechnology company developing cell-based regenerative medicine therapies using adult stem cells. The company is advancing BRTX-100, an autologous mesenchymal stem cell therapy for disc and spine disorders, and a brown adipose-derived cell therapy program targeting obesity and metabolic diseases.